
AnPac Bio-Medical Science Co., Ltd. ANPC
Annual report 2022
added 12-27-2025
AnPac Bio-Medical Science Co., Ltd. Cash Conversion Cycle 2011-2026 | ANPC
Annual Cash Conversion Cycle AnPac Bio-Medical Science Co., Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -204 | -50.1 | 1.86 | -21.2 | 1.99 | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.99 | -204 | -54.2 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
205 | $ 19.69 | 2.39 % | $ 920 M | ||
|
BioMarin Pharmaceutical
BMRN
|
733 | $ 55.38 | 2.38 % | $ 10.6 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
-54.4 | - | - | $ 546 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Cara Therapeutics
CARA
|
52.4 | - | -3.03 % | $ 260 M | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
CRISPR Therapeutics AG
CRSP
|
1.1 K | $ 47.3 | 1.87 % | $ 4.25 B | ||
|
Cyclacel Pharmaceuticals
CYCC
|
-1.6 K | - | -5.98 % | $ 34.1 M | ||
|
CytomX Therapeutics
CTMX
|
12.2 | $ 4.39 | 3.42 % | $ 606 M | ||
|
ChemoCentryx
CCXI
|
3.1 | - | - | $ 3.74 B | ||
|
Dynavax Technologies Corporation
DVAX
|
459 | - | - | $ 2.02 B | ||
|
BioDelivery Sciences International
BDSI
|
340 | - | -4.8 % | $ 255 M | ||
|
Eton Pharmaceuticals
ETON
|
115 | $ 24.37 | 6.1 % | $ 656 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
50 | $ 4.54 | 5.29 % | $ 870 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Brickell Biotech
BBI
|
149 | - | -5.38 % | $ 6.06 M |